| pubmed-article:10586334 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10586334 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
| pubmed-article:10586334 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10586334 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:10586334 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:10586334 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:10586334 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:10586334 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:10586334 | pubmed:dateCreated | 1999-12-22 | lld:pubmed |
| pubmed-article:10586334 | pubmed:abstractText | Treatment of both Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL) with abdominal presentation at the time of diagnosis is often followed by detection of residual masses by computed tomography (CT). However, CT is usually unable to discriminate between residual tumor and fibrosis/necrosis. We investigated the ability of fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to differentiate between residual active tumor tissue and fibrosis. | lld:pubmed |
| pubmed-article:10586334 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10586334 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10586334 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10586334 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10586334 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10586334 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:10586334 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:TuraSS | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:FerlinGG | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:ZompatoriMM | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:GherlinzoniFF | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:ZinzaniP LPL | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:BendandiMM | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:ChierichettiF... | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:CelliniCC | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:MagagnoliMM | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:StefoniVV | lld:pubmed |
| pubmed-article:10586334 | pubmed:author | pubmed-author:GarraffaGG | lld:pubmed |
| pubmed-article:10586334 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10586334 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10586334 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10586334 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10586334 | pubmed:pagination | 1181-4 | lld:pubmed |
| pubmed-article:10586334 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:meshHeading | pubmed-meshheading:10586334... | lld:pubmed |
| pubmed-article:10586334 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10586334 | pubmed:articleTitle | The role of positron emission tomography (PET) in the management of lymphoma patients. | lld:pubmed |
| pubmed-article:10586334 | pubmed:affiliation | Institute of Hematology and Medical Oncology Seràgnoli, University of Bologna, Italy. seragnol@kaiser.alma.unibo.it | lld:pubmed |
| pubmed-article:10586334 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10586334 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10586334 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10586334 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10586334 | lld:pubmed |
